 TCTMD | Boston Scientific receives CE mark for everolimus-eluting coronary stent Equities.com Nov 02, 2012 (Datamonitor via COMTEX) -- Boston Scientific Corporation, a medical device company, has received CE mark approval for the SYNERGY everolimus-eluting platinum chromium coronary stent system featuring an ultra-thin abluminal, or outer, ... COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All ... Boston Scientific Boosts Portfolio - Analyst Blog |
